People should talk with their doctor about whether, when, and how to deprescribe psychostimulants.

Harold Robert Meyer | The ADD Resource Center
haroldmeyer@addrc.org   http://www.addrc.org/  
Reviewed 03/01/2026 – Published 03/07/2026

​​Listen to understand, not just to respond

Note: This is not medical advice. Making any changes on your own can lead to catastrophic results.

When to raise the question

YReasons to talk with your prescriber include (ncbi.nlm.nih)

• You have been stable on the same dose for about a year or more, with few or no recent dose changes.
• You notice you do reasonably well on days you miss your dose or during brief “drug holidays.”
• Side effects (sleep, appetite, cardiovascular issues, mood, tics, anxiety) are troubling or getting worse.
• New health conditions (e.g., heart disease, hypertension, substance use disorder, pregnancy planning) change your risk–benefit balance.
• Your life demands have changed (less academic/workload pressure, different job, retirement).
• You feel over‑medicated, emotionally “flat,” or that benefits no longer justify the burden.
• You are misusing the stimulant, feel pressured to share/sell it, or worry about dependence or diversion.
• Cost, access, or supply problems make ongoing treatment difficult, and you want to plan safely rather than stop abruptly.

It is usually recommended to have at least an annual review of whether medication is still needed, including the family’s preferences, current benefits, side effects, and functioning at school, home, and work.

What to discuss with your doctor

A deprescribing conversation should be structured, not casual. Helpful points to cover include:

• Diagnosis and history: How strong the original ADHD diagnosis is, what other conditions you have, and how you responded to stimulants over time.
• Current benefits: Focus, organization, driving safety, school/work performance, impulsive behavior, and emotional regulation on vs. off medication.
• Risks and adverse effects: Blood pressure/heart rate, weight and appetite, sleep, mood, tics, anxiety, misuse risk, and any cardiovascular or psychiatric history.
• Environment and supports: Demands at school/work, family structure, therapy, coaching, accommodations, and lifestyle strategies that might help if the dose is reduced.
• Past off‑medication periods: How you did during vacations, weekends, supply shortages, or intentional drug holidays.

Ask your prescriber to clearly explain the realistic best and worst‑case outcomes of reducing or stopping the stimulant and what safety plan will be in place if symptoms return or mood worsens.

How deprescribing is usually done (only) by your doctor (pmc.ncbi.nlm.nih)

Most experts recommend a planned, monitored reduction rather than an unplanned stop, even though classic physiological withdrawal from stimulants is uncommon.

Typical elements of a gradual deprescribing plan might include:

• Individualized decision: Choice to deprescribe is made case‑by‑case, not automatically, and should be revisited regularly.
• Small dose steps: Gradual dose reductions (for example, stepwise decreases every 1–2 weeks) to allow your brain and daily routine to adapt.
• Limited trial period: A defined trial (often a few weeks) with clear criteria for success or for resuming medication if functioning deteriorates.
• Multi‑setting monitoring: Feedback from you and, when relevant, parents, teachers, or partners about attention, behavior, driving, work output, and mood.
• Non‑medication supports: Increased emphasis on behavioral strategies, environmental changes, coaching, therapy, sleep, and exercise to cushion any decline in focus or impulse control.ncbi.nlm.nih+2

Some clinicians may judge that a stimulant can technically be stopped abruptly, but doing so can still cause rebound ADHD symptoms, fatigue, irritability, or mood changes, especially after long‑term or higher‑dose use; a taper or brief, structured trial off medication generally reduces these problems and allows quicker adjustment of the plan.You must ensure that any changes you make are based solely on the advice of your healthcare provider.

Warning signs and when to seek urgent help

Make sure to ask your doctor whether there are any negative signs to look for whenever any changes are made.

If changes are made, ensure you understand them clearly and request written instructions.

During any taper or pause, contact your prescriber promptly (or urgent/emergency services if severe) if you or your child experience:

• Sudden, marked worsening in impulsivity, aggression, or risky behavior (e.g., driving, substance use, self‑harm).
• Major deterioration in functioning at school, work, or home that does not improve with environmental adjustments.
• New or rapidly worsening depression, anxiety, agitation, or suicidal thinking.
• Worrisome physical symptoms such as chest pain, shortness of breath, marked blood pressure changes, or severe sleep disruption.

Because reactions vary widely, no one should attempt to deprescribe stimulants alone; decisions about if, when, and how to taper should always be made collaboratively with a qualified healthcare professional who knows the person’s full medical and psychosocial history.

About the Author

Harold Meyer established The A.D.D. Resource Center in 1993 to provide ADHD education, advocacy, and support. He co-founded CHADD of New York, served as CHADD’s national treasurer, and was president of the Institute for the Advancement of ADHD Coaching. A writer and international speaker on ADHD, he has presented at the American Psychiatric Association and CHADD National annual meetings, led school boards and task forces, conducted workshops for educators, and contributed to early online ADHD forums.  

About The ADD Resource Center

Evidence-based ADHD coaching and consultation for individuals, couples, groups, and corporate clients.

Contact: info@addrc.org | +1 (646) 205-8080
127 West 83rd St., Unit 133, Planetarium Station, New York, NY 10024-0840 USA

Follow: “X” | LinkedIn | Substack | ADHD Research and Innovation

Newsletter & Community

Join our community for the latest resources and insights: HaroldMeyer@addrc.org
To unsubscribe, email addrc@mail.com with “Unsubscribe” in the subject line.

Disclaimers

Content is for educational purposes only and should not replace professional advice. While we strive for accuracy, errors may occur. Some content may be AI-generated; readers should verify information independently.

*Rejection Sensitive Dysphoria (RSD) is recognized by many healthcare providers but is not officially listed in the DSM, which may affect diagnosis and treatment approaches.

In the USA and Canada, call or text 988 for free, 24/7 mental health and suicide prevention support. The ADD Resource Center is independent from this service.

Privacy & Legal

Under GDPR and CCPA, you have the right to access, correct, or delete your personal data. Contact info@addrc.org for requests.

© 2026 Harold R. Meyer/ADD Resource Center. All rights reserved. Content may only be shared in complete, unaltered form with proper attribution. Cannot be reproduced or used commercially without written permission. If you reproduce this article, please inform us at addrc.org.